GL1X · GenesisL1 explorer

Research workbench

Crystal structure of pmsf-treated human chymase at 1.9 ångströms resolution

Analyse Crystal structure of pmsf-treated human chymase at 1.9 ångströms resolution in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1KLT
Type
protein
Length
226 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Chymase
EC
3.4.21.39
UniProt
P23946
Ligands
PMS
Pockets
1 · best druggability 0.44

Structure

x-ray diffraction · 1 distinct chain · 9% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AChymase (EC 3.4.21.39)protein2269% helix, 38% strandP23946

Ligands and binding sites

  • PMS · phenylmethanesulfonic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11080.440.7828PMS

Modifications

Observed in the structure: 3 disulfide, 1 covalent (disulfide, covalent ligand).

Compared structures

  • 1KLT · Crystal structure of pmsf-treated human chymase at 1.9 ångströms resolution · the same entry in another collection · chain A against A, TM-score 1.00
  • P23946 · AlphaFold monomer V2.0 prediction for chymase (P23946) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.